Literature DB >> 11510824

High-sensitivity electron capture dissociation tandem FTICR mass spectrometry of microelectrosprayed peptides.

K Håkansson1, M R Emmett, C L Hendrickson, A G Marshall.   

Abstract

Electron capture dissociation (ECD) has previously been shown by other research groups to result in greater peptide sequence coverage than other ion dissociation techniques and to localize labile posttranslational modifications. Here, ECD has been achieved for 10-13-mer peptides microelectrosprayed from 10 nM (10 fmol/microL) solutions and for tryptic peptides from a 50 nM unfractionated digest of a 28-kDa protein. Tandem Fourier transform ion cyclotron resonance (FTICR) mass spectra contain fragment ions corresponding to cleavages at all possible peptide backbone amine bonds, except on the N-terminal side of proline, for substance P and neurotensin. For luteinizing hormone-releasing hormone, all but two expected backbone amine bond cleavages are observed. The tandem FTICR mass spectra of the tryptic peptides contain fragment ions corresponding to cleavages at 6 of 12 (1545.7-Da peptide) and 8 of 21 (2944.5-Da peptide) expected backbone amine bonds. The present sensitivity is 200-2000 times higher than previously reported. These results show promise for ECD as a tool to produce sequence tags for identification of peptides in complex mixtures available only in limited amounts, as in proteomics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11510824     DOI: 10.1021/ac010141z

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  16 in total

1.  Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry.

Authors:  John E P Syka; Joshua J Coon; Melanie J Schroeder; Jeffrey Shabanowitz; Donald F Hunt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

2.  Infrared multiphoton dissociation (IRMPD) and collisionally activated dissociation of peptides in a quadrupole ion trap with selective IRMPD of phosphopeptides.

Authors:  Matthew C Crowe; Jennifer S Brodbelt
Journal:  J Am Soc Mass Spectrom       Date:  2004-11       Impact factor: 3.109

3.  Electron capture dissociation implementation progress in Fourier transform ion cyclotron resonance mass spectrometry.

Authors:  Yury O Tsybin; John P Quinn; Oleg Yu Tsybin; Christopher L Hendrickson; Alan G Marshall
Journal:  J Am Soc Mass Spectrom       Date:  2008-03-04       Impact factor: 3.109

Review 4.  Mass spectrometry in chronic kidney disease research.

Authors:  Michael L Merchant
Journal:  Adv Chronic Kidney Dis       Date:  2010-11       Impact factor: 3.620

5.  Characterization of amino acid side chain losses in electron capture dissociation.

Authors:  Helen J Cooper; Robert R Hudgins; Kristina Håkansson; Alan G Marshall
Journal:  J Am Soc Mass Spectrom       Date:  2002-03       Impact factor: 3.109

6.  Investigation of the presence of b ions in electron capture dissociation mass spectra.

Authors:  Helen J Cooper
Journal:  J Am Soc Mass Spectrom       Date:  2005-10-25       Impact factor: 3.109

7.  Electron transfer ion/ion reactions in a three-dimensional quadrupole ion trap: reactions of doubly and triply protonated peptides with SO2*-.

Authors:  Sharon J Pitteri; Paul A Chrisman; Jason M Hogan; Scott A McLuckey
Journal:  Anal Chem       Date:  2005-03-15       Impact factor: 6.986

8.  Influence of charge state and amino acid composition on hydrogen transfer in electron capture dissociation of peptides.

Authors:  Takashi Nishikaze; Mitsuo Takayama
Journal:  J Am Soc Mass Spectrom       Date:  2010-08-21       Impact factor: 3.109

9.  Systems proteomics for translational network medicine.

Authors:  D Kent Arrell; Andre Terzic
Journal:  Circ Cardiovasc Genet       Date:  2012-08-01

10.  Identification of mammalian cell lines using MALDI-TOF and LC-ESI-MS/MS mass spectrometry.

Authors:  Xu Zhang; Mark Scalf; Travis W Berggren; Michael S Westphall; Lloyd M Smith
Journal:  J Am Soc Mass Spectrom       Date:  2006-02-17       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.